Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

Learn how Portugal’s biotech and life sciences ecosystem is advancing research, startups, and innovation even amid funding ...

3B Pharmaceuticals is developing both therapeutic and diagnostic radiopharmaceuticals for oncology applications. The focus of its drug development programs is a theranostic approach using diagnostic ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...